Methods: Data abstracted from 146 patients treated for chlorine exposure in one emergency department during a 2005 train derailment and 152 patients not exposed to chlorine (a comparison group) were mapped to 93 possible signs/ symptoms within 2 tools (WISER and CHEMM-IST) designed to assist emergency responders/emergency nurses with managing hazardous material exposures. Inferential statistics (χ 2 /Fisher's exact test) and diagnostics tests were used to examine mapped signs/symptoms of persons who were and were not exposed to chlorine.
Results: Three clusters of signs/symptoms are statistically associated with an IGSA syndrome (P b .01): respiratory (shortness of breath, wheezing, coughing, and choking); chest discomfort (tightness, pain, and burning), and eye, nose and/or throat (pain, irritation, and burning). The syndrome requires the presence of signs/symptoms from at least 2 of these clusters.
R E S E A R C H Contribution to Emergency Nursing Practice
•Chemical exposures daily pose a significant threat to life. Rapid assessment by first responders/emergency nurses is required to reduce death and disability. Currently, no informatics tools for Irritant Gas Syndrome Agents (IGSA) exposures exist to process victims efficiently, continuously monitor for latent signs/ symptoms, or make triage recommendations.
•This study uses actual patient data from a chemical incident to characterize and validate signs/symptoms of an IGSA Syndrome. Validating signs/symptoms is the first step in developing new emergency department informatics tools with the potential to revolutionize the process by which emergency nurses manage triage victims of chemical incidents.
The latency period must also be considered for exposed/ potentially exposed persons. [1] [2] [3] [4] A study of the January 2005 Graniteville SC chlorine disaster that killed 9 persons and sent hundreds to the local community hospital found that usual triage systems do not recognize signs and symptoms specific to irritant gas syndrome agents (IGSA) or latent signs of respiratory distress associated with chemical exposures. [1] [2] [3] [4] IGSA gasses/liquids (also known as choking lung or pulmonary agents) include such chemicals as chlorine anhydrous ammonia and sulfur dioxide and may cause severe irritation and swelling of the respiratory tract (lining of the nose throat and lungs). 5, 6 None of the triage systems analyzed in our previous study 1 demonstrated efficacy in establishing priorities for treatment of chlorine victims. Furthermore no informatics tools currently exist to help first responders and emergency nurses process victims efficiently, continuously monitor for latent signs and symptoms or provide triage recommendations for IGSA exposures. [1] [2] [3] [4] To mitigate the "surge" of casualties into emergency departments after a chemical mass casualty incident (MCI) informatics solutions are needed so emergency nurses can quickly and accurately identify, process and triage patients. This study describes the validation of the signs and symptoms of an IGSA syndrome using patient data from an actual incident. This validation is the first step in the development of an IGSA triage algorithm that will soon be incorporated into a new prototype informatics tool to revolutionize the process by which emergency nurses manage triage victims of chemical incidents.
IGSAs are important in manufacturing raw materials and are transported daily through communities by railcar, truck, and barge. 7, 8 Exposure to IGSAs can happen in a variety of settings, including those that involve a deliberate release of these agents (eg, global terrorism), resulting in injury or death to hundreds or thousands of people. The United States Department of Homeland Security estimated that an attack on a large urban chlorine gas storage tank used in municipal water supply and sewage treatment could kill 17,500 people, severely injure 10,000, and hospitalize 100,000. 9 Even the best-prepared city is not capable of coping with an MCI of this magnitude. To manage the "surge" of casualties into a health care facility after an MCI, emergency responders and emergency nurses use triage to rapidly assess patients and prioritize their care with the goal of saving as many lives as possible. 10, 11 Typical field triage such as Simple Triage and Rapid Treatment (START) 12 uses only 4 parameters to assess a triage treatment priority: ability to walk, respirations, perfusion (pulse or capillary refill), and ability to follow simple directions. ED triage tools such as the Emergency Severity Index (ESI) 13 include the assessment of patients requiring immediate life-saving interventions (level 1) and high-risk situations, such as patients who are confused, lethargic, disoriented, in severe pain, or have danger zone vital signs (level 2). Data analysis for the Graniteville study showed an overestimate of the victims classified as levels 1 and 2 using the ESI triage system and an underestimate of red (immediate) victims by the START/JumpSTART (pediatric START) system. 1 Patients exposed to chemicals can experience dramatic and latent changes in signs and symptoms (specifically low oxygen saturation) and thus require ongoing monitoring and evaluation, a factor that current triage systems do not consider. 1 Triage algorithms specific to IGSA exposures are needed to accurately determine the priority of care. 1, 4 Two main challenges are encountered in the treatment of victims of IGSA MCIs: (1) rapidly identifying the chemical involved and (2)identifying, triaging, and processing the persons who are exposed with accuracy, precision, and efficiency to improve patient outcomes. 1 Informatics solutions that improve early identification, processing, and triage for patients admitted to the emergency department after an IGSA exposure will enhance the application of science in emergency nursing and disaster informatics. The use of actual data from a chemical incident to validate the signs and symptoms of an IGSA syndrome will be used in the development of a new ED triage algorithm specific to IGSA incidents. This validation is the first step in the development of an informatics tool that will incorporate the IGSA triage algorithm to help emergency nurses accurately and efficiently detect an MCI, identify an IGSA syndrome, and triage patients during a chemical MCI. 4, 6 Methods Only de-identified data were used for this study. The Office of Research Compliance at the University determined that this study was exempt from the protection of human subject's regulations. All information from the paper medical records of the 198 patients seen in the emergency department at the local hospital within 24 hours of the chlorine incident were abstracted (146 patients were exposed to chlorine, and 52 patients were not exposed to chlorine). Ten years later, in the same hospital and in the same month of the year, information was abstracted from the first 100 patients admitted to the emergency department that day. These 100 patients plus the 52 patients not exposed the day of the actual disaster serve as the comparison group for the study. The data were abstracted, organized, and exported using Research Electronic Data Capture (REDCap), 14 a secure Web application. All data were mapped (ie, matched) to 93 signs and symptoms within 2 decision support tools designed by experts in medicine and emergency response (ie, from the US Department of Health and Human Services and the National Library of Medicine) to assist emergency responders and emergency nurses with hazardous material incidents. The Wireless Information System for Emergency Responders (WISER) 15 requires users to select signs and symptoms that a patient is experiencing from 79 possible signs and symptoms. The tool then queries its database to determine a list of possible chemicals to which the patient may have been exposed. The Chemical Hazards Emergency Medical Management-Intelligent Syndrome Tool (CHEMM-IST) 6 requires users to answer 14 questions about the patient's signs and symptoms, and the tool then queries its database. This query results in a prediction of the likelihood that the patient may have been exposed to a chemical or chemicals from 1 of 4 categories (ie, knockdown, pesticide, acute solvent, and IGSA). These 2 tools provided a comprehensive framework of 93 signs and symptoms for mapping actual signs and symptoms of the 298 patients in order to characterize the IGSA syndrome. The signs and symptoms of persons who were and were not exposed to chlorine were analyzed using inferential statistics (χ 2 /Fisher's exact test) and diagnostics tests (SAS/STAT 9.4, SAS Institute, Cary, NC). The mean number of signs and symptoms mapped to WISER and CHEMM-IST was then calculated. Table 1 shows actual patient signs and symptoms that mapped to WISER and CHEMM-IST. Tables 2 and 3 show sensitivity, specificity, positive predictive value, negative predictive value, false-positive probability, false-negative probability, and 95% confidence interval for WISER and CHEMM-IST.
Results
The results showed good sensitivity for both WISER and CHEMM-IST, from 0.84 to 0.94 and 0.92 to 0.97, respectively, and poor specificity for both WISER and CHEMM-IST, from 0.31 to 0.47 and 0.29 to 0.33, respectively. The positive predictive value and negative predictive values for WISER varied from 0.45 to 0.87 and 0.33 to 0.88, respectively; the positive predictive value for CHEMM-IST varied from 0.18 to 0.42, but the negative predictive value was excellent, ranging from 0.88 to 0.97. The false-positive probability for both WISER and CHEMM-IST was poor, ranging from 0.53 to 0.69 for WISER and 0.67 to 0.71 for CHEMM-IST. The false negative probability was excellent for both WISER and CHEMM-IST, ranging from 0.06 to 0.16 for WISER and 0.03 to 0.08 for CHEMM-IST. Table 4 shows the mean number of patient signs and symptoms mapped to WISER and CHEMM-IST by exposure. The result showed that the mean number of patient signs and symptoms for WISER was 7.2 compared with 2.2 for CHEMM-IST.
Discussion
Clinical signs and symptoms of an IGSA exposure depend upon the route of exposure (inhalation, skin/eye contact, or ingestion). 15 The Graniteville 2005 incident related primarily to inhalational exposures; therefore, this study validated signs and symptoms based on such an exposure. During a chemical MCI, when patient needs outstrip resources, patients must be triaged with particular emphasis given to the chemical's impact on the respiratory system-an impact that may not be evident until after initial triage occurs. Exposed or potentially exposed patients whose signs and symptoms have yet to manifest should be monitored until the end of the latency period for that specific chemical. The study data show good sensitivity for the signs and symptoms mapped to WISER and CHEMM-IST (Tables 2  and 3 ): the sensitivity suggests that 84% to 97% of patients with signs and symptoms will be correctly categorized as having been exposed to the chemical. The study showed poor specificity for the signs and symptoms mapped to WISER and CHEMM-IST (Tables 2 and 3 ): the specificity suggests that only 29% to 47% may be correctly diagnosed as not having been exposed.
Not all patients presenting to the emergency department during a chemical MCI have been exposed to the IGSA. For example, patients may present to the emergency department during a chemical MCI with coughing, a symptom commonly experienced with an upper respiratory infection (URI). Table 2 indicates that a patient experiencing the signs and symptoms of a cough has a 68% chance of being diagnosed with an IGSA exposure when actually experiencing a URI (false-positive probability), which could result in overtriaging for an IGSA exposure. Conversely, this same patient has only a 14% chance of not being diagnosed with an IGSA exposure if exposed (false-negative probability). During an MCI, categorizing patients wrongly as having not been exposed must be avoided to ensure that a patient with a high priority for treatment is not missed. The persons with false-positive results may be overtriaged with a diagnosis of an IGSA exposure, especially in the winter months when URIs may have similar signs and symptoms as an IGSA.
Using the WISER and CHEMM-IST frameworks, the context of a chemical MCI, and analysis of the data, the IGSA syndrome was characterized using the most sensitive signs and symptoms organized into 3 clusters. The following signs and symptoms are statistically associated with an IGSA syndrome (P b .01):
• Respiratory: shortness of breath, wheezing, coughing and choking • Chest discomfort: tightness, pain, and burning • Eye, nose and/or throat: pain, irritation, and burning Based on the mean number of signs and symptoms for WISER (7.2) and for CHEMM-IST (2.2), the analysis indicates that the characterization of an IGSA syndrome must include the presence of signs and symptoms from at least 2 of these clusters. Some IGSAs have a latency period that must also be considered when determining a plan of treatment for exposed or potentially exposed persons.
Limitations
The ability to collect accurate, timely, and valid data at the time of an incident is difficult. Data are often missing and/or challenging to collect. 1 Although this study used a small sample size, it is one of the first studies to use actual patient data from a chemical MCI to validate an ISGA syndrome. In 2005 the community hospital that received the victims from the Graniteville disaster had not implemented electronic medical records and used paper forms for documentation. In reality, during an MCI, many hospitals continue to have paper forms available as a backup plan if computers are not available. Medical record data for this study were abstracted from more TABLE 2 Sensitivity, specificity, positive predictive value, negative predictive value, false-positive probability, false-negative probability, and 95% confidence interval for signs/symptoms mapped to WISER than 20 different paper forms that contained conflicting information about the presence of relevant signs and symptoms. Documentation of time was often missing, and notes were written in the margins of the forms. The abstractors used free text boxes during their data abstraction to note any problems or issues with illegible entries, unconventional abbreviations, and the like. Three experienced emergency nurses on the research team conferred to resolve these issues. With the requirement that public and private health care providers comply with the American Recovery and Reinvestment Act 16, 17 to adopt and demonstrate meaningful use of electronic records, the limitation of paper records as the primary form of health data collection is becoming obsolete. If the Graniteville data had been captured electronically, manual abstraction of the data would not have been necessary, thus minimizing the challenges.
Implications for Emergency Nurses
To mitigate the "surge" of casualties into a health care facility after an MCI, nurses use triage to rapidly assess patients and prioritize their care with the goal of saving as many lives as possible. [1] [2] [3] [4] [5] [6] [7] [8] [9] Mitchell et al 18 stress the need for triage competency training of emergency nurses to manage chemical exposures. Usual ED triage is intended to sort traditional patients seen in the emergency department; it is not designed or effective for patients presenting with exposures to an IGSA. Depending on the dose and route of an IGSA exposure, signs and symptoms may not be evident until damage at the cellular level occurs. Irritation of the mucous membranes of the eyes, nose, and throat is painful and obvious, but it is the damage to the tracheobronchial tree and below that begins the cascade of physiologic assaults that may result in death. The latency period from obvious damage to subtle and lethal destruction must be known so that the patient is monitored for sufficient time to detect and mitigate the damage. Pulse oximetry is an excellent indicator of the integrity of the respiratory tract 1, 4 and will be a key parameter of the IGSA triage algorithm being developed and the informatics tool under design.
Conclusion
This study is the first known study that uses actual patient data from a chemical incident to characterize the signs and symptoms of an IGSA syndrome. The characterization of signs and symptoms related to an IGSA syndrome is the first step in the development of a triage algorithm specifically designed for IGSA incidents. Once the IGSA triage algorithm is fully developed and tested, it will be incorporated into a computer informatics tool that is being designed to help emergency nurses accurately and efficiently detect an MCI, identify an IGSA syndrome, and accurately triage patients during a chemical MCI. A spill of such chemicals moving through a major city or used for global terrorism could injure or kill hundreds of thousands of people. Improvements in algorithms and disaster informatics related to ED triage during IGSA MCIs could save thousands of lives. TABLE 3 Sensitivity, specificity, positive predictive value, negative predictive value, false-positive probability, false-negative probability, and 95% confidence interval for signs/symptoms that mapped to CHEMM-IST False-positive probability (95% CI)
False-negative probability (95% 
